Researchers discover genes behind antibiotic resistance in deadly superbug infections
13 September 2023
Australian researchers have uncovered new genetic insights into Staphylococcus aureus, revealing what makes the bacterium so dangerous when it enters the blood.
Stroke patient thankful for MSU
11 September 2023
It was Geoff’s young grandson who first noticed that something wasn’t quite right with his grandfather. After his family called triple zero (000), the Mobile Stroke Unit (MSU) was dispatched. (Photo: Herald Sun)
The RMH neurologist receives $2 million to advance MND research and care
04 September 2023
The RMH neurologist and The Florey Institute researcher Dr Thanuja Dharmadasa has received funding for three grants in a record investment from FightMND.
Rolling out the rainbow carpet
21 August 2023
Our LGBTIQA+ Patient Liaison Service provides support to patients and families throughout their hospital journey, working closely with multidisciplinary teams to enhance and improve LGBTIQA+ safety and inclusion.
SAD-AF: World-first trial looks at SSRIs and depression in atrial fibrillation
16 August 2023
Dr Youlin Koh
New partnership to improve mental health and wellbeing support
10 August 2023
The Royal Melbourne Hospital (RMH) and the University of Melbourne will lead a collaboration of service providers and institutions focussing on adult and older Australians as part of the State Government’s Victorian Collaborative Centre for Mental Health and Wellbeing.
Stroke patient reunited with lifesaving team
08 August 2023
This week is Stroke Week and in a heartfelt reunion, members from our Mobile Stroke Unit (MSU) team were reunited with stroke patient, Sebastian.
Experts say physiotherapy should be added to cancer patient recovery
03 August 2023
Researchers at the Royal Melbourne Hospital (RMH) say blood cancer patients should think about adding physiotherapy interventions to their treatment plans.
Studying effectiveness of AHSCT in highly active relapsing-remitting MS patients
28 July 2023
Researchers from the Royal Melbourne Hospital (RMH) have conducted a ground-breaking study comparing different treatment options for highly active relapsing-remitting multiple sclerosis (MS) patients who have shown limited response to conventional therapies.
